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low to Sympathetic Stimulation Are Associated
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iao-Li Zhang, MD, PHD,* Michael Kreissl, MD,* Nobuhisa Magosaki, MD,† Hanjoerg Just, MD,†
lrich Solzbach, MD†
os Angeles, California; Freiburg, Germany; and Aarau, Switzerland
OBJECTIVES We sought to assess prospectively whether patients with normal coronary angiograms but
with impaired myocardial blood flow (MBF) increases to cold pressor testing (CPT) are at
increased risk for cardiovascular events.
BACKGROUND Invasive angiographic assessments of coronary vasomotor function have demonstrated an
impairment of endothelium-related coronary flow increases to independently predict future
cardiovascular events. It is unknown whether noninvasive positron emission tomography
(PET)-measured MBF alterations to sympathetic stimulation with CPT are associated with
the risk of developing cardiovascular events.
METHODS A total of 72 patients (44 men, 28 women, age 58  8 years) referred for diagnostic cardiac
catheterization were studied. Myocardial blood flow was measured in absolute units with
13N-ammonia using PET, at baseline and during CPT in each patient. Cardiovascular events
(cardiovascular death, acute coronary syndrome, myocardial infarction, percutaneous trans-
luminal coronary angioplasty, coronary artery bypass grafting, ischemic stroke, or peripheral
revascularization) were assessed as clinical outcome parameters over a mean follow-up period
of 66  8 months. Patients were assigned to three groups: group 1, patients with 40%
increase in MBF (%MBF), n 22; group 2, patients with0 and40% increases in MBF,
n  32; and group 3, patients with decreases in MBF (0%), n  18.
RESULTS During follow-up, one of the group 1 patients developed a cerebral stroke. In group 2, 15
cardiovascular events occurred in 9 patients and in group 3, 7 patients experienced 9
cardiovascular events (p  0.0001, univariate by log-rank test). Impaired MBF increases in
group 2 and group 3 were associated with a significantly higher incidence of cardiovascular
events by Kaplan-Meier analysis (p  0.033, log-rank test). After adjusting for known
coronary risk factors, MBF responses to CPT revealed a nonsignificant trend to be
independently associated with a higher incidence for cardiovascular events (p  0.065,
multivariate by Cox regression model).
CONCLUSIONS Noninvasive PET-measured impaired MBF increases to sympathetic stimulation are associ-
ated with the risk of developing cardiovascular events. (J Am Coll Cardiol 2005;45:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.0401505–12) © 2005 by the American College of Cardiology Foundation
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aormal functioning of the vascular endothelium guarantees
mportant antiatherosclerotic and antithrombotic effects (1).
ndothelial dysfunction, on the other hand, is considered an
ndependent predictor of subsequent cardiovascular events,
mplying important diagnostic and prognostic information
2–5).
The techniques currently and commonly used for the
ssessment of coronary vasomotor function are invasive
1,6), namely, quantitative angiography and intracoronary
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Manuscript received September 26, 2004; revised manuscript received January 19,
005, accepted January 25, 2005.elocity probes for evaluating changes in coronary flow to
cetylcholine-stimulation of endothelial-derived nitric oxide
elease or flow-dependent alterations of the lumen of the
picardial conduit vessels. Coronary flow increases can be
nduced by either intracoronary administration of smooth-
uscle-cell-relaxing substances such as papaverine and adeno-
ine, by the use of physical exercise as hyperemic stimulus, or
y sympathetic stimulation with cold pressor testing (CPT)
3,7–10). Changes in the luminal area of the epicardial
essel during sympathetic stimulation with CPT were ob-
erved to significantly correlate with increases in coronary
lood flows. Thus, information on flow-dependent and
ndothelium-related coronary vasomotion can be derived
rom measurements of coronary blood flow (6,8,11). How-
ver, the invasiveness of coronary angiography does not
llow a more widespread clinical use (11,12). Therefore, an
ptimal test for prognostic evaluation of coronary circula-
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Myocardial Blood Flow and Prognosis May 3, 2005:1505–12ory function should be noninvasive. In this regard, positron
mission tomography (PET)-measured myocardial blood
ow (MBF) combined with CPT has proven to be a reliable
oninvasive index of flow-mediated and, at least in part,
ndothelium-related coronary circulatory function (8,9).
With this in mind, we aimed to evaluate whether patients
resenting impaired MBF increases to CPT but without
ngiographic evidence for coronary artery disease, as as-
essed noninvasively with PET imaging, are at increased
isk for cardiovascular events.
ETHODS
atient population and study design. The study popula-
ion consisted of 72 patients (44 men and 28 women, mean
ge, 58  8 years) who were referred for diagnostic coronary
ngiography between January 1997 and October 2000 for
valuation of persistent chest pain. A prerequisite for study
nclusion was the absence of angiographic evidence for coro-
ary artery disease, as indicated by smooth coronary vessels
ithout evidence of luminal wall irregularities or diffuse caliber
eduction and stenosis. Within 20 days (mean 12  5 days),
ET measurements of MBF at baseline and during CPT were
erformed (8). All patients demonstrated normal wall motion
n left ventriculography (n 38) or on echocardiography (n
4). Screening was accomplished by obtaining a complete
istory, physical examination, and laboratory analyses. Patients
ith a history of acute coronary syndrome; myocardial infarc-
ion; hypertrophic obstructive and nonobstructive cardiomyop-
thy; congestive heart failure; malignant hypertension; valvular
eart disease; or significant endocrine, hepatic, renal, or in-
ammatory disease were excluded from the study. Vasoactive
edications, including calcium-channel blockers, angiotensin-
onverting enzyme inhibitors, statins, long-acting nitrates, and
eta-blockers were withheld from the participant at least 24 h
efore the PET study.
Risk factors such as hypertension, hypercholesterolemia,
moking, and a positive family history for coronary artery
isease were evaluated at the time of registering the alter-
tions of MBF by PET combined with CPT. Hypertension
as defined as a well-established history of chronically (at
east two years) elevated blood pressure (BP) (140/90 mm
g) without any apparent underlying cause that was treated
ith antihypertensive drugs by the primary physician. Hy-
ercholestertolemia was defined as fasting total serum cho-
Abbreviations and Acronyms
BP  blood pressure
CPT  cold pressor test
CVR  coronary vascular resistance
HR  heart rate
MBF  myocardial blood flow
PET  positron emission tomography
RPP  rate-pressure product
SPECT  single-photon emission computed tomographyesterol values 240 mg/dl. Moreover, elevated low-density Mipoprotein cholesterol and triglycerides were defined by
evels 155 mg/dl and 200 mg/dl, respectively, and
ormal high-density lipoprotein cholesterol by 35 mg/dl.
Diabetes mellitus was identified based on standard crite-
ia implying fasting plasma glucose obtained consistently on
ore than two occasions at 126 mg/dl. Chronic smoking
as defined as a history of smoking one pack of cigarettes
or at least the past 10 years, consecutively (13). However,
ll smokers refrained from smoking 12 h before assess-
ent of MBF changes to sympathetic stimulation by PET.
positive family history for coronary artery disease was
efined as evidence of premature coronary artery disease in
parent with respect to gender before 60 years of age. Body
ass index was calculated as weight (kg) divided by height
m)2. Furthermore, in each patient, traditional C-reactive
rotein plasma levels were routinely measured (turbidimet-
ic test, Boehringer Mannheim, Mannheim, Germany), and
he normal range was determined to be between 0 to 0.5
g/dl. The noninvasive assessment of MBF changes to
PT by PET imaging and clinical follow-up were approved
y the local ethics committee of the University of Freiburg.
ll patients gave written informed consent.
ET study protocol. Within 20 days of diagnostic coro-
ary angiography, quantitative estimates of MBF in ml/g/
in were assessed noninvasively with intravenous 13N-
mmonia, serial image acquisition by PET (951 ECAT,
iemens, Erlangen, Germany) and a two-compartment
racer kinetic model as described previously (14). The
elative myocardial perfusion was assessed visually on reori-
ntated static 13N-ammonia images. Measurements were
erformed first at baseline and then during CPT (8,9).
ime-activity curves were generated from the first 12
erially acquired short-axis slices on 3 midventricular slices,
fter assigning the myocardial regions-of-interest to the
erritories of the left anterior descending artery, left circum-
ex artery, and right coronary artery (14,15). The regional
BF values were averaged to calculate mean MBF.
Heart rate (HR), BP, and a 12-lead electrocardiogram
ere recorded continuously. From the average of HR and
P during the first 2 min of each image acquisition, the
ate-pressure product (RPP) was determined as an index of
ardiac work. Further, an index of coronary vascular resis-
ance (CVR) was calculated as the ratio of mean arterial BP
o MBF in order to account for interindividual variations in
he coronary driving pressure. Thus, in each patient, MBF
valuated at baseline and during CPT with PET established
oronary circulatory function (8,9). The decision to divide
atients into three different groups was based on the
reviously described close association between CPT-
nduced changes of epicardial luminal area and MBFs (8).
n the latter study, a flow-related increase of epicardial
essel diameter during CPT, indicative for normal
ndothelium-dependent vasomotion, was associated with an
pproximate 30% to 40% increase in MBF. Accordingly, we
efined normal flow-mediated coronary vasoreactivity as an
BF increase higher than 40% to CPT (MBF 40%),
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May 3, 2005:1505–12 Myocardial Blood Flow and Prognosishile an impaired or even decreased MBF during CPT was
egarded as abnormal coronary vasoreactivity (MBF
40% and MBF 0%) (8). Based on these assumptions,
atients were assigned to 3 groups: group 1, patients with
MBF 40% (n  22); group 2, patients with MBF
etween0 and40% (n 32); and group 3, patients with
MBF 0% (n  18). In addition, patients were grouped
nto MBF 28% (n  45) and MBF 28% (n  27) to
PT according to flow values deviating outside  2 SD
imits of normal values on the basis of MBF responses
btained previously in a normal study population (8).
ong-term follow-up. After a minimum of 12 months, all
atients were contacted for the assessment of clinical end
oints. In view of previous investigations (2–4), cardiovas-
ular death, myocardial infarction, acute coronary syndrome,
ercutaneous transluminal coronary angioplasty, coronary by-
ass grafting, ischemic stroke, and peripheral revasculariza-
ion were defined as cardiovascular events. The assessment
f clinical end points was based on responses to a question-
aire that was sent to patients and primary physicians. All
nformation regarding potential cardiovascular events was
alidated by documentation, including the analysis of re-
eated coronary angiograms, hospital discharge letters, or
ospital chart reviews. Death from any cause was docu-
ented. Cardiovascular death was defined as death attrib-
table to myocardial or cerebral infarction or documented
udden cardiac death. Acute coronary syndrome was defined
s hospitalization due to unstable angina pectoris of Braun-
ald classification IIB or IIIB. Myocardial infarction was
efined as an elevation of creatine kinase levels 2  the
pper limit of normal and/or new ST elevations (0.1 mV)
n 2 leads. Percutaneous transluminal coronary angio-
lasty was counted when performed in a newly developed
de novo) stenosis (luminal narrowing 50%), which was
stimated as hemodynamically significant, or when per-
ormed in acute coronary syndromes due to plaque rup-
ure without hemodynamically significant coronary lesions
Table 1. Characteristics of Study Population
Gro
Patients, n 2
Gender, female 9 (
Age, yrs 58 
BMI, kg/m2 25 
Hypertension, n (%) 2 (
Hypercholesterolemia 2 (
Smoking 0
Diabetes 0
Positive history of CAD 2 (
Lipid status
Serum cholesterol levels, mg/dl 171 
Serum LDL level, mg/dl 102 
Serum HDL level, mg/dl 58 
Triglyceride level, mg/dl 92 
Glucose level, mg/dl 90 
CRP level, mg/dl 0.23 
Values are mean  SD or n (%). *p  0.05 versus group 1
BMI  body mass index; CAD  coronary artery disease; CR
LDL  low-density lipoprotein.uring the follow-up. Ischemic stroke was defined as clini-
al evidence of stroke without intracranial hemorrhage on
rain imaging studies. Cardiovascular medication such as
ngiotensin-converting enzyme inhibitors, statins, calcium-
hannel blockers, and beta-blockers, diuretics, oral anti-
iabetics (such as metformin, sulfonylurea, or alpha-
lucosidase inhibitors), insulin therapy, and nitroglycerin
hat could affect both coronary vasomotor function to CPT
nd/or disease progression were documented.
tatistical analysis. Data of baseline characteristics, MBF
esponses to CPT, and cardiovascular events during
ollow-up are expressed as mean  SD or n (%). Compar-
son between groups was performed by the Wilcoxon or the
ruskal-Wallis test for quantitative variables and by the
isher exact test for qualitative data with Bonferroni after
djusting for multiple comparisons. Cumulative event rates
or both groups were estimated by the method of Kaplan-
eier by log-rank test. The log-rank test was used for
nivariate comparisons of groups with no event. Multivar-
ate analysis using Cox regression techniques was applied to
valuate the potential interactions among the entered co-
ariates. The variables included in the model were age,
ender, arterial hypertension, serum cholesterol levels,
moking, diabetes mellitus, positive family history for cor-
nary artery disease, body mass index, C-reactive protein
evels, and MBF responses to CPT. Medical therapy was
ot entered into the multivariate model as co-medication
as highly correlated with its indications (coronary risk
actors). Results are presented as relative risks with corre-
ponding 95% confidence intervals and p values from
ald’s test. Statistical significance was assumed if the null
ypothesis could be rejected at the p  0.05 level.
ESULTS
linical characteristics at baseline. Patients characteristics
re summarized in Table 1. Group 2 and group 3 presented
Group 2 Group 3
32 18
13 (41) 5 (28)
57  9 58  8
25  4 24  4
17 (53)* 11 (61)*
19 (59)* 9 (50)*
8 (25)* 10 (56)*
3 (9)* 1 (6)*
9 (28)* 3 (17)*
234  38* 228  38*
154  22* 147  14*
44  10* 51  11
128  60* 148  63*
100  13* 99  14*
2.13  1.05* 2.26  1.46*
lcoxon signed-rank test.up 1
2
40)
7
3
9)
9)
9)
40
32
8
42
6
0.25
by Wi
P  C-reactive protein; HDL  high-density lipoprotein;
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Myocardial Blood Flow and Prognosis May 3, 2005:1505–12ore coronary risk factors than group 1. In group 1, the
ipid profile was within normal range. In groups 2 and 3,
otal cholesterol and low-density lipoprotein levels were
ignificantly higher than group 1 (p  0.05). No significant
ifferences in total cholesterol, low-density lipoprotein cho-
esterol, and high-density lipoprotein cholesterol were noted
etween groups 2 and 3 (p  NS). Although the glucose
evels in all three groups were within normal limits, groups
and 3 had significantly higher levels than group 1 (p 
.05). The body mass index, however, was not significantly
ifferent between the groups (p  NS). Finally, groups 2
nd 3 had significantly higher C-reactive protein levels than
roup 1 (0.05), although there were no significant differ-
nces between groups 2 and 3 (p  NS).
emodynamics. Hemodynamic parameters of all three
roups during PET-measured MBFs at baseline and during
PT are given in Table 2. The RPP served as an index of
ardiac work and as a measure of the effectiveness of
ympathetic stimulation attributable to cold exposure. In all
hree groups, CPT stimulated a significant increase in HR,
ystolic and diastolic BP (p  0.05) that was comparable
mong the groups (pNS). In each group, the correspond-
ng RPP significantly increased during CPT (p  0.05),
ndicative for a marked sympathetic activation due to CPT.
owever, the percent change of RPP (%RPP) in response
o CPT was not significantly different between the groups
p  NS), indicating comparable hemodynamic study con-
itions during the PET study.
able 2. Hemodynamics During PET Studies at Baseline and D
Group 1
Rest CPT R
R, beats/min 59  8 65  9* 60
BP, mm Hg 129  11 150  13* 135
BP, mm Hg 71  7 76  7* 76
PP 7,624  1,291 9,825  1,633* 8,086
RPP 29  11%*
ata expressed as mean  SD.
*p  0.05 CPT versus rest for each corresponding hemodynamic parameter in dif
CPT  cold pressor test; DBP  diastolic blood pressure; HR  heart rate; PE
heart rate); SBP  systolic blood pressure; %RPP  percent change of RPP fro
Table 3. Mean MBF Responses and Coronary
Group
Grou
MBF (ml/g/min)
Before CPT 0.70 
After CPT 1.25 
% Change 83 
 Change 0.55 
Coronary vascular resistance
(mm Hg/ml·g1·min1)
Before CPT 140 
After CPT 88 
% Change 37 
 Change 53 Values are mean  SD or n (%). *p  0.05 vs. group 1 by Wilcox
CPT  cold pressor test; MBF  myocardial blood flow.BF responses to CPT. Table 3 demonstrates the mean
alues of MBF at baseline and during CPT and the
orresponding absolute and percent change in MBF
MBF and %MBF) in each study group. At baseline,
BF did not differ significantly between group 1 and group
(p  NS) (Table 3), while group 3 presented a signifi-
antly higher MBF (p  0.01). Cold pressor test-induced
hanges revealed a significantly impaired increase in MBF
n groups 2 and 3 compared to group 1, respectively (Table
) (p  0.0001). In addition, the decrease of MBF during
PT in group 3 was significantly different from the diminished
ncrease of MBF in group 2 (p 0.0001). Because changes of
VR mirrored the MBF responses to CPT for each study
roup (Table 3), differences in hemodynamic responses do not
ccount for the observed alterations in MBFs.
linical events during follow-up. Cardiovascular events
re summarized in Table 4. The mean period of follow-up
as 66  8 months. During follow-up, 17 of 72 patients
24%) suffered at least one cardiovascular event. In group 1,
nly one patient experienced a transient ischemic stroke.
owever, in group 2, 15 cardiovascular events, and, in
roup 3, 9 cardiovascular events occurred in 9 and 7
atients, respectively (p  0.0001, univariate by log-rank
est).
The cumulative proportion of cardiovascular event-free
urvival according to the MBF responses to CPT for all
hree groups is shown in Figure 1. As a rule, patients with
CPT
Group 2 Group 3
CPT Rest CPT
65  9* 61  5 66  6*
157  15* 137  14 159  17*
82  8* 74  10 79  10*
42 10,162  1,537* 8,306  1,061 10,524  1,287*
27  10%* 27  8%*
study evaluations, respectively.
ositron emission tomography; RPP  rate pressure product (systolic blood pressure
t during CPT.
ular Resistance to CPT for Each Study
Group 2 Group 3
0.71  0.21 0.84  0.15*
0.82  0.24* 0.72  0.19*
17  10%* 16  10%*
0.11  0.07* 0.12  0.07*
145  38 115  23*
140  37* 156  48*
3  10%* 56  48%*
5  15* 41  29*uring
est
 8
 15
 8
 1,4
ferentVasc
p 1
0.18
0.36
26%
0.21
42
27
9%
23on signed rank test.
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May 3, 2005:1505–12 Myocardial Blood Flow and Prognosisbnormal MBF increases to CPT (groups 2 and 3) demon-
trated a significantly higher incidence of cardiovascular
vents compared to patients with normal MBF increases
group 1) (p  0.033, log-rank test). It is noteworthy that
he incidence of cardiovascular events increased with the
egree of an abnormal MBF response to CPT in groups 2
nd 3 compared to group 1 (p  0.024, respectively) (Fig. 2).
n addition, patients with MBF 28% to CPT revealed a
ignificantly higher incidence of cardiac events compared
ith the group of MBF 28% (p  0.026, log-rank test)
Fig. 3).
eterminants of prognosis. Impaired MBF increases to
PT, C-reactive protein levels, smoking, hypercholesterol-
mia, and diabetes were significantly associated with the
ccurrence of cardiovascular events during the follow-up on
nivariate analysis (Table 5). Age, gender, body mass index,
ypertension, and a positive family history of coronary ar-
ery disease were not associated with a poor clinical outcome
igure 1. Kaplan-Meier analysis demonstrating the proportion of patients
ithout cardiovascular events during long-term follow-up in patients with
able 4. Cardiovascular Events During Long-Term Follow-Up
n  72)
Group 1
(n  22)
Group 2
(n  32)
Group 3
(n  18)
udden cardiac death 0 0 1
cute coronary syndrome 0 5 1
yocardial infarction (nonfatal) 0 4 1
oronary angioplasty 0 5 6
oronary bypass surgery 0 0 0
eripheral arterial bypass surgery 0 1 0
schemic stroke 1 0 0
atients with at least one
cardiovascular event, n (%)
1 (5) 9 (28) 7 (39)ormal (group 1), impaired (group 2), and decreased (group 3) myocardial
lood flow to cold pressor test.
i
pTable 5). In addition, in group 2 and 3, neither statin
herapy nor angiotensin-converting enzyme inhibition was
ssociated with improved long-term outcome by Cox
odels.
In order to test whether impaired MBF increases to CPT
ere independent predictors of developing cardiovascular
vents, a multivariate analysis was performed. As shown in
able 5A, impaired MBF increases to CPT approached a
onsignificant trend (p  0.065) to independently predict
uture cardiovascular events. C-reactive protein levels, age,
ender, and a positive family history of coronary artery
isease did not have a significant effect on the multivariate
nalysis. Conversely, independent predictors of cardiovas-
ular events were hypercholesterolemia, hypertension, smo-
igure 2. Patients with at least one cardiovascular event, n (%). Open bar 
roup 1; striped bar  group 2; solid bar  group 3.
igure 3. Kaplan-Meier analysis demonstrating the proportion of patients
ithout cardiac events during long-term follow-up in patients with changen myocardial blood flow (MBF) 28% and with MBF 28% to cold
ressor test.
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Myocardial Blood Flow and Prognosis May 3, 2005:1505–12ing, and increases in body mass index (Table 5A). Thus, in
he current study population, impaired MBF responses to
PT were not entirely independent from coronary risk
actors associated with a higher risk to develop cardiovas-
ular events. The additional multivariate analysis implying
ardiac events only (Table 5B) yielded similar results.
owever, impaired MBF responses to CPT no longer
howed a trend to independently predict future cardiac
vents.
ISCUSSION
he present study is the first of its kind to demonstrate that
atients with normal coronary angiograms but with im-
aired MBF increases in response to CPT, as measured
oninvasively with PET, are at increased risk for cardiovas-
ular events. These observations are in accordance with
ndings of recent invasive angiographic studies (2–5,16) in
atients with either no apparent or with more advanced
tages of coronary artery disease. The latter findings extend
o the site of coronary arteriolar vessels by noninvasive
stimates of MBF responses to sympathetic stimulation.
bnormal coronary vasomotion and prognosis. The uni-
ariate analysis revealed that classical coronary risk factors
uch as hypercholesterolemia, diabetes mellitus, smoking,
-reactive protein plasma levels, and impaired MBF in-
reases attributable to sympathetic activation were signifi-
antly associated with the occurrence of future cardiovascu-
ar events. After adjusting for known coronary risk factors by
ultivariate analysis, diminished MBF increases to CPT
evealed a nonsignificant trend to be independently associ-
ted with a higher incidence for cardiovascular events.
urther, patients with severely impaired MBF increases to
ympathetic activation demonstrated a higher incidence of
ardiovascular events than patients with moderately im-
aired MBF increases, despite a similar profile in coronary
isk factors. Thus, with regard to the early development of
therosclerosis, this study may provide some first evidence,
ut certainly not the final answer, that noninvasively PET-
able 5. Univariate and Multivariate Cox Regression Analysis in
ardiac Events (B)
Variable
A Mult
Univariate p Relative Risk (9
mpaired MBF to CPT 0.025* 1.03 (0.998–1
rterial hypertension 0.215 0.07 (0.009–0
moking 0.001* 0.12 (0.019–0
ypercholesterolemia 0.015* 0.10 (0.016–0
iabetes 0.026* 0.21 (0.023–1
MI 0.525 7.90 (1.593–3
RP mg/dl 0.0001* 1.77 (0.923–3
ge 0.274 0.99 (0.926–1
ender 0.850 0.40 (0.111–1
ositive family history of coronary
artery disease
0.806 1.50 (0.303–7
p  0.05.
BMI  body mass index; CI  confidence interval; CPT  cold pressor test; Ceasured impaired MBF increases to sympathetic activa- iion could be useful as an integrating index of the overall
tress burden imposed by various risk factor states on the
rterial wall at the level of the coronary resistance vessels.
Clinical assessment of coronary vasomotor function has
emonstrated that impaired endothelium-dependent vaso-
otion of the coronary circulation in response to various
timuli such as sympathetic stimulation with CPT, intra-
oronary acetylcholine application, or coronary flow in-
reases with flow-mediated changes in vessel diameter is
ignificantly associated with the occurrence of cardiovascular
vents (2–5,16). Increased attention has been focused on the
oncept that the integrity of the coronary resistance vessels
onstitutes an important factor in counteracting the devel-
pment and progression of coronary atherosclerotic disease
1,17). This is due to the magnitude of coronary blood flow
ncreases during times of increased metabolic demand that
etermines the amount of flow-mediated endothelial release
f nitric oxide of the epicardial conduit vessels (6,11,18,19),
mplying numerous antithrombotic and antiatherosclerotic
ffects. If this holds true, then conversely, impaired flow-
ediated and, thus, endothelium-related vasodilation of
picardial arteries, reflecting the integrity of shear-stress-
nduced nitric oxide release, should be predictive for the
ccurrence of cardiovascular events. And indeed, dimin-
shed flow-mediated vasodilatory responses at the site of the
picardial conduit vessels to coronary flow increases have
een demonstrated to independently predict future cardio-
ascular events (3). This is in line with the observation of
he current study as the noninvasive assessment of impaired
BF increases to sympathetic stimulation with PET im-
ging in patients with normal coronary angiograms proved
o be significantly associated with a subsequent risk of
eveloping cardiovascular events.
However, there is abundant evidence for the prognostic
alue of exercise-induced ischemic myocardial perfusion
ingle-photon emission computed tomography (SPECT)
20 –23). In the clinical setting, myocardial perfusion
PECT imaging has emerged as an important tool for
tudy Group (n  72) Implying Cardiovascular Events (A) or
te B Multivariate
I) p Univariate p Relative Risk (95% CI) p
0.065 0.009* 1.01 (0.977–1.044) 0.556
0.008* 0.245 0.05 (0.006–0.474) 0.008*
0.025* 0.001* 0.12 (0.016–0.841) 0.033*
0.013* 0.006* 0.10 (0.015–0.713) 0.021*
0.151 0.019* 0.32 (0.034–3.055) 0.323
0.011* 0.851 5.29 (0.950–29.42) 0.052*
0.085 0.0001* 1.48 (0.775–2.895) 0.254
0.803 0.078 0.95 (0.885–1.027) 0.206
0.168 0.838 0.57 (0.143–2.251) 0.421
0.621 0.050* 1.47 (0.269–7.772) 0.667
C-reactive protein; MBF  myocardial blood flow.the S
ivaria
5% C
.057)
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.375)mproving the diagnostic assessment and risk stratification
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May 3, 2005:1505–12 Myocardial Blood Flow and Prognosisf patients with suspected coronary artery disease. Never-
heless, there may be a substantial number of patients with
ubclinical atherosclerosis and normal myocardial perfusion
PECT studies (23). Conceptually, in patients with normal
yocardial perfusion SPECT the noninvasive-assessment
f MBF alterations to sympathetic stimulation with CPT
ould help to unmask a subset of patients at increased risk
or cardiovascular events. The current study, although small
n number, provides first evidence that PET-measured
BF alterations in response to sympathetic activation is
ssociated with a higher risk for future cardiovascular events.
f note, the incidence of cardiovascular events increased
ith the degree of the CPT-induced abnormal MBF
esponse. Similar findings of increasing incidence of cardio-
ascular events with the magnitude of vasoconstriction of
picardial conduit arteries and of coronary arteriolar vessels
n response to intracoronary acetylcholine application has
een reported in previous invasive angiographic investiga-
ions (4,5). Importantly, these studies also suggest dimin-
shed coronary blood flow increases to acetylcholine stimu-
ation, reflecting endothelium-dependent vasoreactivity at
he site of the coronary resistance vessels, to identify patients
t increased risk for future cardiovascular events. Thus, the
atter observations (4,5) and the findings of the present
tudy indicate that impaired coronary flow increases are
ssociated with a poor clinical outcome.
It is worthy to note that even though there is a close
elationship between coronary risk factor burden and abnor-
al coronary vasomotor function (1), a considerable vari-
bility in the magnitude of impaired endothelium-dependent
ascular function in individuals with comparable risk profiles
ay exist (4,24). In this scenario, abnormal coronary vaso-
otor function may indeed be regarded as an useful inte-
rating index of the overall stress burden imposed by various
oronary risk factors on the arterial wall, taking into account
he cumulative risk of coronary risk factors and as yet
nknown variables and genetic predispositions (1,25). This
otion is supported by findings in the clinical assessment of
oronary vascular function (3,4), which have demonstrated
hat, even in the presence of atherosclerosis, endothelial
ysfunction of the coronary circulation remains an indepen-
ent predictor of disease progression and cardiovascular
vents. These important findings attest to the results of
ishimura et al. (26), which revealed a dissociation between
ndothelial-dependent coronary vasoreactivity to acetylcho-
ine stimulation and the atherosclerotic burden of the
rterial wall as assessed by intravascular ultrasound. It then
ollows that functional alterations of coronary vasomotion
ay provide a reflection of on-going processes that modify
he functional status of the vessel wall. In contrast, mor-
hological changes of the epicardial vessels as assessed by
ntravascular ultrasound or the noninvasive with X-ray-
omputed-tomography-measured epicardial calcification
ay represent the propensity of the individual to develop
therosclerotic plaque burden as a consequence to long-
asting effects of coronary risk factors (23,26). In this retting, it may be intriguing to speculate that functional
lterations of coronary vasomotion may provide a reliable
easure in predicting short-term risk, while noninvasive
easures of coronary calcium burden may reflect more the
ong-term risk (3,4,23,26). Because abnormal coronary vas-
ular function has been implicated as an early event in the
evelopment and progression of atherosclerosis, improve-
ent of functional disorders of the coronary vessels by a
ariety of interventions such as angiotensin-converting en-
yme inhibitors, statins, physical exercise, and antioxidants
as become of general interest (1,17). Importantly, whether
edical intervention tailored to reverse abnormal coronary
ascular function is, indeed, related to an improvement in
linical outcome remains to be established (27). The assess-
ent of MBF alterations to sympathetic stimulation and/or
harmacologically induced hyperemia by PET imaging
ould be a promising tool in patient care management to
uccessfully guide preventive medical intervention. Concep-
ually, PET-determined changes in MBF could also be used
s a surrogate marker for the evaluation of new therapeutic
trategies.
tudy limitations. There are limitations worthy of consid-
ration in interpreting our data. First, although only a
inority of the study population had diabetes, we cannot
xclude that, in these patients, diabetic neuropathy could
ave potentially affected the MBF responses to CPT (28).
econd, we did not perform intravascular ultrasound to
ssess the epicardial wall structure. Therefore, we cannot
ule out the presence of diffuse atherosclerosis or eccentric
laques of the epicardial coronary arteries. Third, the results
resented were obtained from a group of patients referred
or coronary angiography to evaluate persistent chest pain.
hus, these findings may not necessarily be generalizable to
atients in a primary care setting. Fourth, the three groups
n our study differed significantly with regard to traditional
oronary risk factors. This fact univariately explains some of
he differences in the incidence of cardiovascular events
etween the groups. Yet, as shown in a multivariate analysis,
djusting for traditional coronary risk factors, impaired
BF increases to CPT revealed a trend to be independently
ssociated with the risk of developing cardiovascular events,
hough statistically the trend only reached borderline sig-
ificance (p  0.065). When the analysis was limited to
ardiac end points, however, no trend of an independent
redictive value of impaired MBF increases to CPT was
ound any longer (p 0.506). In view of the relatively small
ample size of the study population and the borderline
redictive value of impaired MBF increases to CPT for a
oor clinical outcome, the current study does not provide
efinite answers but may stimulate further clinical investi-
ations in this evolving research field. Consequently, to
etermine definite conclusions regarding an incremental
rognostic value of abnormal MBF responses to CPT,
arger prospective investigations in patients with hemody-
amically nonobstructive coronary artery disease, similar
isk profile, and/or at low risk are needed. Finally, because
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asodilation in these patients, further clinical studies are
ecessary to explore the prognostic implications of nonin-
asive PET-measured MBF increases to pharmacologic
asodilation.
onclusions. In patients with normal coronary angio-
rams, impaired MBF increases attributable to sympathetic
ctivation, as assessed noninvasively with PET, are associ-
ted with the risk of developing cardiovascular events.
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